Ramsay Health Care drops 12% despite committing to cost outs

The private hospital operator reported full-year revenue of $17.8 billion, up 6.8%.

| More on:
Health professional working on his laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Ramsay Health Care Limited (ASX: RHC) has posted a marginal increase in underlying net profit after tax, while analysts say headwinds in its Australian and UK businesses will weigh on the stock.

The private hospital operator reported full-year revenue of $17.8 billion, up 6.8%, while underlying net profit after tax from continuing operations was $305.3 million, up just 1.7%.

Ramsay shares tumbled more than 12% on the news, down $4.93 to $33.16, while RBC Capital Markets analysts said headwinds in the UK and Australian divisions would weigh on the stock.

Transformation on track

Ramsay managing director Natalie Davis said the company was taking "decisive action" to improve returns and had made good headway on its transformation plans.

"Our multi-year transformation is focused around three key strategic priorities: transformation of our market-leading Australian hospital business; strengthening capital discipline and improving returns across the portfolio; and evolving our culture of 'people caring for people' to innovate and drive performance," Ms Davis said.

"In Australia, performance in our core private hospitals business is improving, driven by activity growth and improved indexation from private health insurers.

"To drive revenue growth and operational efficiency in the Australian business, we have established our 'Big 5' hospital initiatives for delivery in FY26."

Ms Davis said Ramsay's UK hospitals business delivered an improved performance in FY25, "benefiting from growth in NHS admissions and higher levels of case acuity".

"Elysium continues to experience significant challenges, and having completed our rapid performance diagnostic in H2, we are taking decisive action to take cost out of the business.

"Ramsay Santé continues to be impacted by reduced government funding support for the private health system in France, with performance in the Nordics being driven by improved results in Sweden.

"We are progressing the evaluation of strategic options in relation to our 52.8% shareholding in Ramsay Sante, with advisors Goldman Sachs. Ramsay remains committed to optimising shareholder returns and is reviewing a range of options."

Ramsay said it had made key leadership appointments in July 2025 in its Australian business, which would support the delivery of its Australia 2030 strategy and ongoing transformation.

Outlook negative for Ramsay

RBC Capital Markets said the outlook for Ramsay was negative in light of the results.

"FY25 revenue was in line with expectations, while underlying EBIT and NPAT were slight beats to market expectations," RBC analysts said in a note to clients.

"The final dividend was also higher than expected. However divisionally, the Australian and UK businesses had weaker margins which were offset by better performance from the France business.

"We expect the stock to underperform due to the weakness in the Australian and UK earnings, headwind from a new funding agreement at the Joondalup campus and higher than expected net financing costs."

Ramsay will pay a fully-franked dividend of 40 cents per share on September 25 to shareholders on the books on September 3.

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

A young man stands facing the camera and scratching his head with the other hand held upwards wondering if he should buy Whitehaven Coal shares
Consumer Staples & Discretionary Shares

ASX 300 stock tumbles despite strong first half profit growth and guidance upgrade

This KFC restaurant operator is performing very positively in FY 2026.

Read more »

A man looking at his laptop and thinking.
Earnings Results

Metcash shares on watch amid $142m first half profit and flat dividend

It is results day for this popular income stock.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Earnings Results

Fisher & Paykel shares surge 8% on half-year results

The market's response was in appreciation of strong results and upgraded guidance.

Read more »

Man sitting in a plane looking through a window and working on a laptop.
Earnings Results

Guess which ASX 200 stock is jumping 14% on record results

This travel technology company had a record half. Let's dig deeper into things.

Read more »

A plumber gives the thumbs up
Earnings Results

Reece 1Q FY26: Revenue growth, profit margin pressures, and a $365m buyback

Reece posted higher revenue but softer profit margins in 1Q FY26.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Earnings Results

ALS reports higher revenue, profit, and dividend for H1 FY26

ALS reported stronger H1 FY26 earnings as Commodities performance drove higher revenue, profit, and a bigger dividend for shareholders.

Read more »

a man in a green and gold Australian athletic kit roars ecstatically with a wide open mouth while his hands are clenched and raised as a shower of gold confetti falls in the sky around him.
Earnings Results

Catapult Sports earnings: ACV and profit hit record highs in 1H FY26

Catapult Sports lifted its ACV by 19% and operating profit by 50% in 1H FY26, while continuing global expansion.

Read more »

Man looking happy and excited as he looks at his mobile phone.
Materials Shares

Why are James Hardie shares jumping 9% today?

Let's see why this blue chip is getting a lot of investor attention from investors on Tuesday.

Read more »